Further areas for drug therapies in SCLC include the apoptotic pathway, the hedgehog and DNA repair pathways, heat shock proteins and HDAC as well as angiogenesis pathways and others [109]. This evidence concerns the gene HDAC9 and small cell lung carcinoma.